Jayathilaka, N.; Pathirana, T.; Kumari, C.; Navaratne, V.; Gunasekara, S.; Nakkawita, D.; Senaratne, T.
Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance. Germs 2023, 13, 314-320.
https://doi.org/10.18683/germs.2023.1400
AMA Style
Jayathilaka N, Pathirana T, Kumari C, Navaratne V, Gunasekara S, Nakkawita D, Senaratne T.
Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance. Germs. 2023; 13(4):314-320.
https://doi.org/10.18683/germs.2023.1400
Chicago/Turabian Style
Jayathilaka, Nishadi, Tharushi Pathirana, Chathurika Kumari, Varuna Navaratne, Samanmalee Gunasekara, Dilini Nakkawita, and Thamarasi Senaratne.
2023. "Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance" Germs 13, no. 4: 314-320.
https://doi.org/10.18683/germs.2023.1400
APA Style
Jayathilaka, N., Pathirana, T., Kumari, C., Navaratne, V., Gunasekara, S., Nakkawita, D., & Senaratne, T.
(2023). Fosfomycin: A Potential Oral Option for Treatment of Urinary Tract Infections in Sri Lanka in the Context of High Antibiotic Resistance. Germs, 13(4), 314-320.
https://doi.org/10.18683/germs.2023.1400
